🇺🇸 FDA
Pipeline program

Tenecteplase

NTA1401a

Phase 2 small_molecule completed

Quick answer

Tenecteplase for Ischemic Stroke is a Phase 2 program (small_molecule) at Neuroscience Trials Australia with 1 ClinicalTrials.gov record(s).

Program details

Company
Neuroscience Trials Australia
Indication
Ischemic Stroke
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials